Serveur d'exploration sur la rapamycine et les champignons - Exploration (Accueil)

Index « KwdFr.i » - entrée « Relation structure-activité (MeSH) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Relation dose-réponse (immunologie) (MeSH) < Relation structure-activité (MeSH) < Remodelage des voies aériennes (physiologie)  Facettes :

List of bibliographic references indexed by Relation structure-activité (MeSH)

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
000341 (2019) Saleem Ahmad [République populaire de Chine] ; Sen Wang [République populaire de Chine] ; Weizhong Wu [République populaire de Chine] ; Kunlong Yang [République populaire de Chine] ; Yan Feng Zhang [République populaire de Chine] ; Elisabeth Tumukunde [République populaire de Chine] ; Shihua Wang [République populaire de Chine] ; Yu Wang [République populaire de Chine]Functional Analysis of Peptidyl-prolyl cis-trans Isomerase from Aspergillus flavus.
000411 (2019) Denise Rageot [Suisse] ; Thomas Bohnacker [Suisse] ; Erhan Keles [Suisse] ; Jacob A. Mcphail [Canada] ; Reece M. Hoffmann [Canada] ; Anna Melone [Suisse] ; Chiara Borsari [Suisse] ; Rohitha Sriramaratnam [Suisse] ; Alexander M. Sele [Suisse] ; Florent Beaufils [Suisse] ; Paul Hebeisen [Suisse] ; Doriano Fabbro [Suisse] ; Petra Hillmann [Suisse] ; John E. Burke [Canada] ; Matthias P. Wymann [Suisse](S)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine (PQR530), a Potent, Orally Bioavailable, and Brain-Penetrable Dual Inhibitor of Class I PI3K and mTOR Kinase.
000483 (2018) Qingwen Huang [République populaire de Chine] ; Lijun Xie [République populaire de Chine] ; Xiaoming Chen [République populaire de Chine] ; Hui Yu [République populaire de Chine] ; Yubing Lv [République populaire de Chine] ; Xuehui Huang [République populaire de Chine] ; Jiayin Ying [République populaire de Chine] ; Congshen Zheng [République populaire de Chine] ; Yuanrong Cheng [République populaire de Chine] ; Jie Huang [République populaire de Chine]Synthesis and anticancer activity of novel rapamycin C-28 containing triazole moiety compounds.
000605 (2018) Ruth Martín [Norvège] ; Sandra Lopez-Aviles [Norvège]Express yourself: how PP2A-B55Pab1 helps TORC1 talk to TORC2.
000999 (2016) Lijun Xie [République populaire de Chine] ; Jie Huang [République populaire de Chine] ; Xiaoming Chen [République populaire de Chine] ; Hui Yu [République populaire de Chine] ; Kualiang Li [République populaire de Chine] ; Dan Yang [République populaire de Chine] ; Xiaqin Chen [République populaire de Chine] ; Jiayin Ying [République populaire de Chine] ; Fusheng Pan [République populaire de Chine] ; Youbing Lv [République populaire de Chine] ; Yuanrong Cheng [République populaire de Chine]Synthesis of Rapamycin Derivatives Containing the Triazole Moiety Used as Potential mTOR-Targeted Anticancer Agents.
000F75 (2013) Yoan R. Monneau [France] ; Heddy Soufari ; Christopher J. Nelson ; Cameron D. MackerethStructure and activity of the peptidyl-prolyl isomerase domain from the histone chaperone Fpr4 toward histone H3 proline isomerization.
001360 (2011) Isabel Rodríguez-Escudero [Espagne] ; María D. Oliver ; Amparo Andrés-Pons ; María Molina ; Víctor J. Cid ; Rafael PulidoA comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes.
001395 (2010) T. Sato [États-Unis] ; A. Nakashima ; L. Guo ; K. Coffman ; F. TamanoiSingle amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer.
001693 (2007) Fumiaki Ikeda [Japon] ; Shigeki Tanaka ; Hidenori Ohki ; Satoru Matsumoto ; Katsuyuki Maki ; Masataka Katashima ; David Barrett ; Yoshiyasu AokiRole of micafungin in the antifungal armamentarium.
001794 (2006) Suzanne D. Clutter [États-Unis] ; James E. Fortney ; Laura F. GibsonChemotherapy disrupts activity of translational regulatory proteins in bone marrow stromal cells.
001808 (2005) Sonja A. Dames [Suisse] ; José M. Mulet ; Klara Rathgeb-Szabo ; Michael N. Hall ; Stephan GrzesiekThe solution structure of the FATC domain of the protein kinase target of rapamycin suggests a role for redox-dependent structural and cellular stability.
001818 (2005) Christine Van Hoof [Belgique] ; Ellen Martens ; Sari Longin ; Jan Jordens ; Ilse Stevens ; Veerle Janssens ; Jozef GorisSpecific interactions of PP2A and PP2A-like phosphatases with the yeast PTPA homologues, Ypa1 and Ypa2.
001840 (2005) E. Foulstone [Royaume-Uni] ; S. Prince ; O. Zaccheo ; J L Burns ; J. Harper ; C. Jacobs ; D. Church ; A B HassanInsulin-like growth factor ligands, receptors, and binding proteins in cancer.
001887 (2004) Edmund I. Graziani [États-Unis] ; Mia Y. Summers ; Jeffrey E. Janso ; Ker Yu ; Valerie S. Bernan ; Michael Greenstein ; Guy T. CarterIsolation, structure determination and biological activity of 15-deoxo-7,32-O-didesmethylrapamycin from the soil actinomycete LL-D45042.
001901 (2004) Jana Narasimhan [États-Unis] ; Kirk A. Staschke ; Ronald C. WekDimerization is required for activation of eIF2 kinase Gcn2 in response to diverse environmental stress conditions.
001959 (2002) Alleyn T. Plowright [États-Unis] ; Scott E. Schaus ; Andrew G. MyersTranscriptional response pathways in a yeast strain sensitive to saframycin a and a more potent analog: evidence for a common basis of activity.
001A04 (2001) A C Gingras [Canada] ; B. Raught ; N. SonenbergRegulation of translation initiation by FRAP/mTOR.
001A94 (1996) A. Bell [Irlande (pays)] ; H C Roberts ; L H ChappellThe antiparasite effects of cyclosporin A: possible drug targets and clinical applications.
001B12 (1995) J I Luengo [États-Unis] ; D S Yamashita ; D. Dunnington ; A K Beck ; L W Rozamus ; H K Yen ; M J Bossard ; M A Levy ; A. Hand ; T. Newman-TarrStructure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface.
001B30 (1994) M J Bossard [États-Unis] ; D J Bergsma ; M. Brandt ; G P Livi ; W K Eng ; R K Johnson ; M A LevyCatalytic and ligand binding properties of the FK506 binding protein FKBP12: effects of the single amino acid substitution of Tyr82 to Leu.
001B34 (1993) P L Koser [États-Unis] ; W K Eng ; M J Bossard ; M M Mclaughlin ; R. Cafferkey ; G M Sathe ; L. Faucette ; M A Levy ; R K Johnson ; D J Bergsma ; G P LiviThe tyrosine89 residue of yeast FKBP12 is required for rapamycin binding.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Relation structure-activité (MeSH)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Relation structure-activité (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Relation structure-activité (MeSH)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020